Table 4.

Effects of upper airway surgery on PSG and lipid parameters (41 cases).

Variables	Group 1 (all cases)			Group 2 (UPPP)			Group 3 (NOSE)
	Baseline	Follow up	p Value	Baseline	Follow up	p Value	Baseline	Follow up	p Value
BMI	26.96±5.69	26.91±5.73	0.61	30.24±6.64	29.73±5.42	0.78	24.27±2.74	24.01±2.85	0.59
ESS score	14.78±5.38	4.08±2.22	<0.01	14.67±4.90	2.94±1.43	<0.01	13.45±5.60	4.77±2.27	<0.01
AHI	41.00±23.31	21.99±16.27	<0.01	42.44±22.51	18.75±9.43	<0.01	39.82±24.4	24.64±20.08	<0.01
AI	27.28 (11.70, 50.55)	11.25 (1.95, 30.06)	<0.01	27.01 (11.90, 50.15)	11.25 (2.40, 28.38)	<0.01	27.28 (4.07, 53.80)	10.75 (1.45, 35.80)	<0.01
HI	4.94 (2.50, 11.15)	8.45 (3.90, 18.96)	0.27	4.03 (2.50, 12.25)	14 (4.73, 34.10)	0.05	6.94 (1.84, 10.50)	6.65 (3.74, 13.00)	0.71
Spo2%	92.43±4.15	94.08±3.27	0.30	91.48±5.56	94.06±4.48	0.14	93.2±2.37	94.09±1.90	0.01
Spo2%min	71.23±15.02	81.23±10.76	<0.01	68.94±16.28	83.44±9.78	<0.01	73.09±14.01	79.41±11.4	0.03
TC	5.13±1.27	4.79±1.00	<0.01	5.45±1.58	4.99±1.07	0.01	4.87±0.90	4.63±0.94	0.06
HDL	1.23±0.29	1.21±0.32	0.71	1.22±0.29	1.25±0.26	0.60	1.23±0.29	1.17±0.37	0.38
LDL	3.02±0.99	2.89±0.74	0.14	3.27±1.18	3.14±0.81	0.34	2.81±0.78	2.68±0.61	0.27
TG	1.96 (1.50, 2.41)	1.80 (1.28, 2.52)	0.23	1.86 (1.39, 2.86)	1.59 (1.21, 2.40)	0.10	1.60 (1.20, 2.40)	1.84 (1.43, 2.87)	0.60
LP(a)	17.30 (13.86, 21.98)	8.10 (2.93, 19.93)	<0.01	18.05 (11.73, 19.93)	6.65 (2.81, 20.33)	<0.01	16.65 (12.80, 20.33)	8.10 (3.00, 20.25)	<0.01

The results are presented as mean ±SD or median (interquartile range).